Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.15 USD | +4.43% | +12.87% | +2.77% |
25/04 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
24/04 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
Sales 2024 * | 535M 44.7B | Sales 2025 * | 577M 48.19B | Capitalization | 851M 71.08B |
---|---|---|---|---|---|
Net income 2024 * | 43M 3.59B | Net income 2025 * | 57M 4.76B | EV / Sales 2024 * | 1.84 x |
Net Debt 2024 * | 132M 11.02B | Net Debt 2025 * | 79M 6.6B | EV / Sales 2025 * | 1.61 x |
P/E ratio 2024 * |
20.2
x | P/E ratio 2025 * |
15.1
x | Employees | 3,500 |
Yield 2024 * |
0.22% | Yield 2025 * |
0.22% | Free-Float | 98.99% |
Latest transcript on Core Laboratories Inc.
1 day | +4.43% | ||
1 week | +12.87% | ||
Current month | +14.87% | ||
1 month | +3.71% | ||
3 months | +27.55% | ||
6 months | -8.56% | ||
Current year | +2.77% |
Managers | Title | Age | Since |
---|---|---|---|
Lawrence Bruno
CEO | Chief Executive Officer | 64 | - |
Christopher Hill
DFI | Director of Finance/CFO | 54 | - |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Curtis Anastasio
BRD | Director/Board Member | 67 | 28/23/28 |
Director/Board Member | 71 | 01/20/01 | |
Director/Board Member | 74 | 01/16/01 |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 18.15 | +4.43% | 600,281 |
13/24/13 | 17.38 | +2.24% | 367,290 |
10/24/10 | 17 | -0.53% | 421,327 |
09/24/09 | 17.09 | +3.95% | 326,416 |
08/24/08 | 16.44 | +2.24% | 296,294 |
Delayed Quote Nyse, May 15, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.77% | 851M | |
0.00% | 7.34B | |
-12.46% | 2.88B | |
-9.52% | 2.77B | |
-29.53% | 1.79B | |
-3.93% | 1.15B | |
-6.53% | 1.07B | |
-12.02% | 821M | |
-0.41% | 756M | |
-17.36% | 737M |
- Stock Market
- Equities
- CLB Stock